Development of [²²⁵Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC

• मुख्य लेखकों: Eline L. Hooijman (लेखक), Yozlem Chalashkan (लेखक), Sui Wai Ling (लेखक), Figen F. Kahyargil (लेखक), Marcel Segbers (लेखक), Frank Bruchertseifer (लेखक), Alfred Morgenstern (लेखक), Yann Seimbille (लेखक), Stijn L. W. Koolen (लेखक), Tessa Brabander (लेखक), Erik de Blois (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2021-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Recently, promising results of the antitumor effects were observed in patients with metastatic castration-resistant prostate cancer treated with ¹⁷⁷Lu-labeled PSMA-ligands. Radionuclide therapy efficacy may even be improved by using the alpha emitter Ac-225. Higher efficacy is...